Cargando…
The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
BACKGROUND: The combination of Hydroxychloroquine (HCQ) and azithromycin showed effectiveness as a treatment for COVID-19 and is being used widely all around the world. Despite that those drugs are known to cause prolonged QT interval individually there is no study assessing the impact of this combi...
Autores principales: | Bakhshaliyev, Nijad, Uluganyan, Mahmut, Enhos, Asim, Karacop, Erdem, Ozdemir, Ramazan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417268/ https://www.ncbi.nlm.nih.gov/pubmed/32827987 http://dx.doi.org/10.1016/j.jelectrocard.2020.08.008 |
Ejemplares similares
-
The impact of hydroxychloroquine–azithromycin combination on Tpeak‐to‐end and Tpeak‐to‐end/QT ratio during a short treatment course
por: Bakhshaliyev, Nijad, et al.
Publicado: (2021) -
Assessment of the Relationship between Monocyte to High-Density
Lipoprotein Ratio and Myocardial Bridge
por: Enhos, Asim, et al.
Publicado: (2019) -
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
P Wave Duration/P Wave Voltage Ratio Plays a Promising Role in the Prediction of Atrial Fibrillation: A New Player in the Game
por: Karacop, E., et al.
Publicado: (2021) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)